(Q24188312)

English

5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction (English)

0 references

author name string

Herney A García-Perdomo

series ordinal

1

0 references

Hugo E Lopez

series ordinal

2

0 references

James Tacklind

series ordinal

3

0 references

publication date

4 November 2015

0 references

published in

Cochrane Database of Systematic Reviews

0 references

cites work

Effect of dutasteride on the risk of prostate cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD011928

retrieved

21 January 2018

Natural history of prostatism: impact of urinary symptoms on quality of life in 2115 randomly selected community men.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD011928

retrieved

21 January 2018

What is "quality of evidence" and why is it important to clinicians?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD011928

retrieved

21 January 2018

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD011928

retrieved

21 January 2018

Natural history of prostatism: risk factors for acute urinary retention

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD011928

retrieved

21 January 2018

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD011928

retrieved

21 January 2018

Phytotherapy of benign prostatic hyperplasia. A minireview.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD011928

retrieved

21 January 2018

The benign prostatic hyperplasia registry and patient survey: study design, methods and patient baseline characteristics

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD011928

retrieved

21 January 2018

The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD011928

retrieved

21 January 2018

Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD011928

retrieved

21 January 2018

Pygeum africanum for benign prostatic hyperplasia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD011928

retrieved

21 January 2018

Finasteride for benign prostatic hyperplasia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD011928

retrieved

21 January 2018

The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD011928

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Benign prostatic hyperplasia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD011928

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD011928

0 references

(Q24188312)

5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)